PPC
ABBV icon

Park Place Capital’s AbbVie ABBV Stock Holding History

Park Place Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Buy
14,307
+4,033
+39% +$868K 0.57% 37
2026
Q1 		$2.23M Buy
10,274
+4,855
+90% +$1.08M 0.45% 39
2025
Q4 		$1.24M Sell
5,419
-584
-10% -$133K 0.26% 65
2025
Q3 		$1.39M Buy
6,003
+10
+0.2% +$2.04K 0.29% 61
2025
Q2 		$1.14M Sell
5,993
-3,307
-36% -$615K 0.26% 70
2025
Q1 		$1.95M Sell
9,300
-1,914
-17% -$372K 0.53% 39
2024
Q4 		$1.99M Buy
11,214
+605
+6% +$111K 0.56% 38
2024
Q3 		$2.09M Sell
10,609
-1,471
-12% -$275K 0.6% 34
2024
Q2 		$2.07M Sell
12,080
-2,022
-14% -$335K 0.66% 34
2024
Q1 		$2.57M Sell
14,102
-4,332
-24% -$747K 0.92% 25
2023
Q4 		$2.86M Buy
18,434
+979
+6% +$143K 1.14% 15
2023
Q3 		$2.6M Buy
17,455
+734
+4% +$108K 0.76% 25
2023
Q2 		$2.25M Sell
16,721
-2,213
-12% -$325K 0.64% 31
2023
Q1 		$3.02M Buy
18,934
+508
+3% +$77.7K 0.85% 22
2022
Q4 		$2.98M Buy
+18,426
New +$2.83M 0.84% 20

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Park Place Capital's ABBV Position: Q2 2026 in Review

Park Place Capital increased its AbbVie (ABBV) stake by 39% in Q2 2026, buying an estimated $868K and bringing the position to 14,307 shares worth $3.6M. The position accounts for 0.57% of the portfolio, ranked #37.

Park Place Capital first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Park Place Capital held 14,307 shares of AbbVie worth $3.6M as of Q2 2026.
  • Park Place Capital bought 4,033 AbbVie shares in Q2 2026, an estimated $868K.
  • AbbVie made up 0.57% of Park Place Capital's portfolio in Q2 2026, its #37 holding.
  • Park Place Capital first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.